Deutsch | English | Français - CHF | EUR | USD
Analysen | Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
 Sie befinden sich in - Suchresultat - Fachinformation zu Iomeron®
Fachinformation zu Iomeron®:Bracco Suisse SA
Vollst. FachinformationDDDÄnderungen anzeigenDrucken
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info.
V08AB10 - IomeprolATC-DDD Version 2016. Source: WHO
V - Various
 

This group comprises many different types of drugs, and assigning DDDs are difficult. Very few DDDs are assigned in this group.

V08 - Contrast Media

This group comprises X-ray, MRI and Ultrasound contrast media. The X-ray contrast media are subdivided into iodinated and non-iodinated compounds, and are further classified according to water solubility, osmolarity and nephrotropic/hepatotropic properties. High osmolar substances correspond mainly to ionic substances, except from ioxaglic acid, which is classified together with the non-ionic substances. MRI contrast media are subdivided according to magnetic properties.

V08A - X-Ray Contrast Media, Iodinated
 
V08AB - Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media
 
V08AB10 - Iomeprol
LGPL2017 ywesee.com, Commit-ID
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home